Search research articles
Contact Us
Filters
Showing results (61-70 of 110) with videos related to
Page
of 11
Sort By:
Journal of Affective Disorders
|
February 15, 2020
Severe insomnia is associated with metabolic syndrome in women over 50 years with major depression treated in psychiatry settings: a METADAP report
Jean-François Costemale-Lacoste, Khalil El Asmar, Adrien Rigal, et al.
Neuropsychobiology
|
September 5, 2025
Exploring Blood Glutamate as a Diagnostic Biomarker for Major Depressive Episodes in a context of Major Depressive Disorder
Khalil El Asmar, Tala El Ghoul, Romain Colle, et al.
International Journal of Molecular Sciences
|
November 11, 2022
Astroglial Connexins Inactivation Increases Relapse of Depressive-like Phenotype after Antidepressant Withdrawal
Benjamin Portal, Flora Vasile, Jonathan Zapata, et al.
Basic & Clinical Pharmacology & Toxicology
|
January 7, 2020
SOD2 genetic polymorphism (rs4880) has no impact on 6-month response to antidepressant treatment and inflammatory biomarkers in depressed patients
Abd El Kader Ait Tayeb, Laurent Becquemont, Khalil El-Asmar, et al.
Pharmacogenomics
|
March 1, 2017
No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients
Eric Deflesselle, Céline Verstuyft, Anne-Cécile Petit, et al.
Psychiatry and Clinical Neurosciences
|
December 5, 2022
Habenular volume in depressed patients
Josselin Etienne, Alexandre Boutigny, Kim Tran Dong Minh Ngoc Thien, et al.
NPJ Biofilms and Microbiomes
|
February 4, 2026
Prucalopride, a serotonin type 4 receptor agonist, induces fast anxiolytic/antidepressant effects and concomitant changes in the gut microbiota
Sofia Cussotto, Salma R Abdennebi, Isabelle Etting, et al.
Brain Stimulation
|
March 13, 2021
Efficacy and safety of adjunctive vagus nerve stimulation in the treatment of resistant depression with psychotic features: A case report
Romain Colle, Abd El Kader Ait Tayeb, Lauriane Delhay, et al.
Fundamental & Clinical Pharmacology
|
May 10, 2023
Intrahippocampal injection of a selective blocker of NMDA receptors containing the GluN2B subunit, Ro25-6981, increases glutamate neurotransmission and induces antidepressant-like effects
Julie Doan, Céline Defaix, Indira Mendez-David, et al.
Psychiatry Research
|
October 28, 2016
Tobacco use is associated with increased plasma BDNF levels in depressed patients
Romain Colle, Séverine Trabado, Samuel Rotenberg, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 110) with videos related to
Sort By:
Page
of 11
Journal of Affective Disorders
|
February 15, 2020
Severe insomnia is associated with metabolic syndrome in women over 50 years with major depression treated in psychiatry settings: a METADAP report
Jean-François Costemale-Lacoste, Khalil El Asmar, Adrien Rigal, et al.
Neuropsychobiology
|
September 5, 2025
Exploring Blood Glutamate as a Diagnostic Biomarker for Major Depressive Episodes in a context of Major Depressive Disorder
Khalil El Asmar, Tala El Ghoul, Romain Colle, et al.
International Journal of Molecular Sciences
|
November 11, 2022
Astroglial Connexins Inactivation Increases Relapse of Depressive-like Phenotype after Antidepressant Withdrawal
Benjamin Portal, Flora Vasile, Jonathan Zapata, et al.
Basic & Clinical Pharmacology & Toxicology
|
January 7, 2020
SOD2 genetic polymorphism (rs4880) has no impact on 6-month response to antidepressant treatment and inflammatory biomarkers in depressed patients
Abd El Kader Ait Tayeb, Laurent Becquemont, Khalil El-Asmar, et al.
Pharmacogenomics
|
March 1, 2017
No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients
Eric Deflesselle, Céline Verstuyft, Anne-Cécile Petit, et al.
Psychiatry and Clinical Neurosciences
|
December 5, 2022
Habenular volume in depressed patients
Josselin Etienne, Alexandre Boutigny, Kim Tran Dong Minh Ngoc Thien, et al.
NPJ Biofilms and Microbiomes
|
February 4, 2026
Prucalopride, a serotonin type 4 receptor agonist, induces fast anxiolytic/antidepressant effects and concomitant changes in the gut microbiota
Sofia Cussotto, Salma R Abdennebi, Isabelle Etting, et al.
Brain Stimulation
|
March 13, 2021
Efficacy and safety of adjunctive vagus nerve stimulation in the treatment of resistant depression with psychotic features: A case report
Romain Colle, Abd El Kader Ait Tayeb, Lauriane Delhay, et al.
Fundamental & Clinical Pharmacology
|
May 10, 2023
Intrahippocampal injection of a selective blocker of NMDA receptors containing the GluN2B subunit, Ro25-6981, increases glutamate neurotransmission and induces antidepressant-like effects
Julie Doan, Céline Defaix, Indira Mendez-David, et al.
Psychiatry Research
|
October 28, 2016
Tobacco use is associated with increased plasma BDNF levels in depressed patients
Romain Colle, Séverine Trabado, Samuel Rotenberg, et al.
Page
of 11